Aclaris Therapeutics GAAP EPS of -$0.12 beats by $0.02, revenue of $3.3M beats by $1.89M

* Aclaris Therapeutics press release [https://seekingalpha.com/pr/20296245-aclaris-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate] (ACRS [https://seekingalpha.com/symbol/ACRS]): Q3 GAAP EPS of -$0.12 beats by $0.02.
* Revenue of $3.3M (-24.1% Y/Y) beats by $1.89M.

MORE ON ACLARIS THERAPEUTICS

* Aclaris Therapeutics, Inc. (ACRS) Discusses At 2025 R&D Day (Transcript) [https://seekingalpha.com/article/4829900-aclaris-therapeutics-inc-acrs-2025-randd-day-conference-call]
* Aclaris Therapeutics, Inc. (ACRS) Special Call - Slideshow [https://seekingalpha.com/article/4829778-aclaris-therapeutics-inc-acrs-special-call-slideshow]
* Seeking Alpha’s Quant Rating on Aclaris Therapeutics [https://seekingalpha.com/symbol/ACRS/ratings/quant-ratings]
* Historical earnings data for Aclaris Therapeutics [https://seekingalpha.com/symbol/ACRS/earnings]
* Financial information for Aclaris Therapeutics [https://seekingalpha.com/symbol/ACRS/income-statement]